A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

Beijing Gaobo Boren Hospital, Beijing

Peking University Third Hospital, Beijing

Peking Union Medical College Hospital, Beijing

The First Hospital of Jilin University, Changchun

Harbin First Hospital, Harbin

Harbin Medical University Cancer Hospital, Harbin

Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School, Nanjing

Shandong Provincial Hospital, Jinan

Hematology Hospital, Chinese Academy of Medical Sciences, Tianjin

The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou

Fujian Medical University Union Hospital, Fuzhou

Guangdong Provincial People's Hospital, Guangzhou

Nanfang Hospital of Southern Medical University, Guangzhou

Sun Yat-sen University Cancer Center, Guangzhou

Shenzhen Second People's Hosptial, Shenzhen